These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19696441)
1. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey. de Marco R; Accordini S; Antò JM; Gislason T; Heinrich J; Janson C; Jarvis D; Künzli N; Leynaert B; Marcon A; Sunyer J; Svanes C; Wjst M; Burney P Am J Respir Crit Care Med; 2009 Nov; 180(10):956-63. PubMed ID: 19696441 [TBL] [Abstract][Full Text] [Related]
2. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800 [TBL] [Abstract][Full Text] [Related]
4. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults. Mehta AJ; Miedinger D; Keidel D; Bettschart R; Bircher A; Bridevaux PO; Curjuric I; Kromhout H; Rochat T; Rothe T; Russi EW; Schikowski T; Schindler C; Schwartz J; Turk A; Vermeulen R; Probst-Hensch N; Künzli N; Am J Respir Crit Care Med; 2012 Jun; 185(12):1292-300. PubMed ID: 22492989 [TBL] [Abstract][Full Text] [Related]
5. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up. Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996 [TBL] [Abstract][Full Text] [Related]
6. COPD in chronic heart failure: less common than previously thought? Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385 [TBL] [Abstract][Full Text] [Related]
7. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Thomsen M; Nordestgaard BG; Vestbo J; Lange P Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615 [TBL] [Abstract][Full Text] [Related]
9. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study. Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748 [TBL] [Abstract][Full Text] [Related]
10. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Mohamed Hoesein FA; Zanen P; Lammers JW Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958 [TBL] [Abstract][Full Text] [Related]
11. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483 [TBL] [Abstract][Full Text] [Related]
12. Six-second spirometry for detection of airway obstruction: a population-based study in Austria. Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719 [TBL] [Abstract][Full Text] [Related]
13. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Wan ES; Hokanson JE; Murphy JR; Regan EA; Make BJ; Lynch DA; Crapo JD; Silverman EK; Am J Respir Crit Care Med; 2011 Jul; 184(1):57-63. PubMed ID: 21493737 [TBL] [Abstract][Full Text] [Related]
14. Can an airway challenge test predict respiratory diseases? A population-based international study. Marcon A; Cerveri I; Wjst M; Antó J; Heinrich J; Janson C; Jarvis D; Leynaert B; Probst-Hensch N; Svanes C; Toren K; Burney P; de Marco R J Allergy Clin Immunol; 2014 Jan; 133(1):104-10.e1-4. PubMed ID: 23683511 [TBL] [Abstract][Full Text] [Related]
15. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up. Zaigham S; Wollmer P; Engström G Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443 [TBL] [Abstract][Full Text] [Related]
16. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983 [TBL] [Abstract][Full Text] [Related]
18. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Lindberg A; Eriksson B; Larsson LG; Rönmark E; Sandström T; Lundbäck B Chest; 2006 Apr; 129(4):879-85. PubMed ID: 16608933 [TBL] [Abstract][Full Text] [Related]
19. Clinical impact of the lower limit of normal of FEV Liu S; Zhou Y; Liu S; Zou W; Li X; Li C; Deng Z; Zheng J; Li B; Ran P Respir Med; 2018 Jun; 139():27-33. PubMed ID: 29857998 [TBL] [Abstract][Full Text] [Related]
20. Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study. Wollmer P; Engström G Respir Med; 2013 Sep; 107(9):1460-2. PubMed ID: 23845882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]